UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness

Biomaterials, 2016-11, Vol.107, p.74-87

2016

Volltextzugriff (PDF)

Ipilimumab-related hypophysitis may precede severe CNS immune attack

Annals of oncology, 2016-10, Vol.27 (10), p.1975-1976

2016

Volltextzugriff (PDF)

Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma

Annals of oncology, 2017-10, Vol.28, p.vii24-vii24

2017

Volltextzugriff (PDF)

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases

Annals of the rheumatic diseases, 2004-04, Vol.63 (4), p.415-419

2004

Volltextzugriff (PDF)

53P A multispecific non-integrating RNA CAR T platform to overcome the clinical challenge of glioblastoma heterogeneity

Annals of oncology, 2021-12, Vol.32, p.S1395

2021

Volltextzugriff (PDF)

59P Oncolytic adenovirus-based therapeutics to target or reprogram glioma-associated macrophages

Annals of oncology, 2021-12, Vol.32, p.S1397

2021

Volltextzugriff (PDF)

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

The Journal of immunology (1950), 2000-12, Vol.165 (12), p.7253-7261

2000

Volltextzugriff (PDF)

234P Oncolytic adenovirus-based therapeutics to reprogram the glioblastoma microenvironment for improved CAR T cell therapy

Immuno-oncology technology, 2022-12, Vol.16, p.100345, Article 100345

2022

Volltextzugriff (PDF)

IgG reactivity against citrullinated myelin basic protein in multiple sclerosis

Journal of neuroimmunology, 2001-07, Vol.117 (1), p.149-155

2001

Volltextzugriff (PDF)

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study

Swiss medical weekly, 2010, Vol.140, p.w13055

2010

Volltextzugriff (PDF)

P-115 PEMREC: A phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized microsatellite stable rectal cancer

Annals of oncology, 2020-07, Vol.31, p.S127

2020

Volltextzugriff (PDF)

IMA950 multipeptide vaccine adjuvanted with poly-ICLC in combination with standard therapy in newly diagnosed HLA-A2 glioblastoma patients

Annals of oncology, 2017-12, Vol.28, p.xi3-xi4

2017

Volltextzugriff (PDF)

Phase I/II study of IMA950 peptide vaccine with Poly-ICLC in combination with standard therapy in newly diagnosed A2 glioblastoma: Preliminary results

Annals of oncology, 2015-11, Vol.26, p.viii1-viii1

2015

Volltextzugriff (PDF)

Development of chimeric antigen receptor (CAR) T cells for immunotherapy of glioma

Annals of oncology, 2015-11, Vol.26, p.viii5-viii5

2015

Volltextzugriff (PDF)

P01.122 Safety, immunogenicity and optimization of the IMA950 multipeptide vaccine combined with Poly-ICLC in newly diagnosed HLA-A2 malignant glioma patients

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii260-iii260

2018

Volltextzugriff (PDF)

Fecal microbiota transplantation from patients with pancreatic cancer into germ-free mice: metataxonomic and metabolic impact

Clinical nutrition ESPEN, 2020-12, Vol.40, p.567-568

2020

Volltextzugriff (PDF)

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (16), p.4499-4506

2000

Volltextzugriff (PDF)

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma

Immunological reviews, 2002-10, Vol.188 (1), p.81-96

2002

Volltextzugriff (PDF)

Interferon beta in multiple sclerosis: relationship between sustained serum IgG levels and clinical outcome

Journal of neuroimmunology, 2002-08, Vol.129 (1), p.232-236

2002

Volltextzugriff (PDF)

Singularité des profils d’autoréactivité systémique en fonction de l’âge: relations avec la susceptibilité au neuropaludisme chez les sujets exposés en région endémique à Abidjan, Côte-d’Ivoire

Bulletin de la Société de pathologie exotique, 2012-10, Vol.105 (4), p.276-283

2012

Volltextzugriff (PDF)

Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL

The Journal of immunology (1950), 2002-11, Vol.169 (10), p.5696-5707

2002

Volltextzugriff (PDF)

Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans

The Journal of experimental medicine, 2002-07, Vol.196 (2), p.207-216

2002

Volltextzugriff (PDF)

Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates with the Stability of MHC/Peptide Multimer Binding to TCR

The Journal of immunology (1950), 2002-02, Vol.168 (3), p.1167-1171

2002

Volltextzugriff (PDF)

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity

Cancer research (Chicago, Ill.), 2001-08, Vol.61 (15), p.5850-5856

2001

Volltextzugriff (PDF)

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients

The Journal of immunology (1950), 2000-07, Vol.165 (1), p.533-538

2000

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(122)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(93)
Life Sciences & Biomedicine
(83)
Humans
(81)
Female
(44)
Biological And Medical Sciences
(35)
Male
(33)
Adult
(29)
Medical Sciences
(28)
Immunology
(24)
Middle Aged
(21)
Animals
(18)
Aged
(14)
Melanoma - Immunology
(12)
Neoplasm Proteins - Immunology
(12)
Oncology
(12)
Peptide Fragments - Immunology
(12)
T-Lymphocytes, Cytotoxic - Immunology
(12)
Antigens, Neoplasm - Immunology
(11)
General & Internal Medicine
(11)
Medicine, General & Internal
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness

Ipilimumab-related hypophysitis may precede severe CNS immune attack

Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases

53P A multispecific non-integrating RNA CAR T platform to overcome the clinical challenge of glioblastoma heterogeneity

59P Oncolytic adenovirus-based therapeutics to target or reprogram glioma-associated macrophages

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

234P Oncolytic adenovirus-based therapeutics to reprogram the glioblastoma microenvironment for improved CAR T cell therapy

IgG reactivity against citrullinated myelin basic protein in multiple sclerosis

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study

P-115 PEMREC: A phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized microsatellite stable rectal cancer

IMA950 multipeptide vaccine adjuvanted with poly-ICLC in combination with standard therapy in newly diagnosed HLA-A2 glioblastoma patients

Phase I/II study of IMA950 peptide vaccine with Poly-ICLC in combination with standard therapy in newly diagnosed A2 glioblastoma: Preliminary results

Development of chimeric antigen receptor (CAR) T cells for immunotherapy of glioma

P01.122 Safety, immunogenicity and optimization of the IMA950 multipeptide vaccine combined with Poly-ICLC in newly diagnosed HLA-A2 malignant glioma patients

Fecal microbiota transplantation from patients with pancreatic cancer into germ-free mice: metataxonomic and metabolic impact

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma

Interferon beta in multiple sclerosis: relationship between sustained serum IgG levels and clinical outcome

Singularité des profils d’autoréactivité systémique en fonction de l’âge: relations avec la susceptibilité au neuropaludisme chez les sujets exposés en région endémique à Abidjan, Côte-d’Ivoire

Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL

Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans

Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates with the Stability of MHC/Peptide Multimer Binding to TCR

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients

Aktive Filter

Suchergebnisse filtern